Systematic Review
Copyright ©The Author(s) 2019.
World J Clin Cases. Nov 6, 2019; 7(21): 3474-3485
Published online Nov 6, 2019. doi: 10.12998/wjcc.v7.i21.3474
Figure 6
Figure 6 Treatment modalities used for thyroid metastases in clear cell renal cell carcinoma patients in the studies population. Systemic therapy included Interferon-a, tyrosine kinase inhibitors, vascular endothelial growth factor inhibitors, alkylating agent (capacitance), interlukin-2, unidentified chemotherapy.